PROPRANOLOL IN ACUTE MIGRAINE - A CONTROLLED-STUDY

被引：10

作者：

FULLER, GN

GUILOFF, RJ

机构：

[1] Department of Neurology, Charing Cross and Westminster Medical School, Westminster Hospital, London S.W., 1P 2AP

来源：

CEPHALALGIA | 1990年 / 10卷 / 05期

关键词：

Acute migraine; controlled study; propranolol;

D O I：

10.1046/j.1468-2982.1990.1005229.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Propranolol is an established agent in migraine prophylaxis. Uncontrolled studies have suggested an action in the acute attack. We present the first double-blind placebo controlled study of propranolol in 27 unselected patients with common (migraine without aura) and classical (migraine with aura) migraine. There were 23 pairs of headaches in the 14 patients who completed the study. No difference was found, when the data were analysed by headache pair or by patient, in severity duration and subjective assessment of efficacy between those treated in an attack with propranolol 40 mg and placebo. © 1990, International Headache Society. All rights reserved.

引用

页码：229 / 233

页数：5

共 11 条

[1]

Weber R.B., Reinmuth O.M., The treatment of migraine with propranolol, Neurology, 22, pp. 366-369, (1972)

[2]

Wideroe T-E., Vigander T., Propranolol in the treatment of migraine, Br Med J, 2, pp. 699-701, (1974)

[3]

Diamond S., Medina J.L., Double blind study of propranolol for migraine prophylaxis, Headache, 16, pp. 24-27, (1976)

[4]

Forssman B., Henriksson K-G., Johannsson V., Lindvall L., Lundin H., Propranolol for migraine prophylaxis, Headache, 16, pp. 238-245, (1976)

[5]

Featherstone H.J., Low dose propranolol therapy for aborting acute migraine, West J., Med, 138, pp. 416-417, (1983)

[6]

Tokola R., Hokkanan E., Propranolol for acute migraine, Br Med J, 2, (1978)

[7]

Fogelholm R., Propranolol and cluster headache, Br Med J, 4, (1972)

[8]

Waters W.E., Controlled clinical trial of ergotamine tartrate, Br Med J, 2, pp. 325-327, (1970)

[9]

JAMA, 179, pp. 717-718, (1962)

[10]

Tfelt-Hansen P., Olesen J., Methodological aspects of drug trials in migraine, Neuroepidemiol, 4, pp. 204-226, (1985)

← 1 2 →